Vogenx (VOGX) sets $11–$13 IPO range targeting $75 million on Nasdaq
As seen on the 24/7 Wall St. homepage on July 29, 2026.
Biotech sets $11 to $13 pricing range on $75 million Nasdaq IPO
Vogenx amended its IPO registration to price 6.25 million shares between $11 and $13 apiece, targeting $75 million in proceeds for the Nasdaq listing.
Continue ReadingShow less
Vogenx, Inc. has amended its IPO registration with the SEC, setting a price range of $11 to $13 per share for 6.25 million shares. At the midpoint of that range, the offering would value the deal at around $75 million, which is also the stated proceeds target the company disclosed in the filing.
The amendment moves Vogenx into a more advanced stage of its Nasdaq listing process. An amended registration typically follows initial feedback from institutional investors during the roadshow, and the tightened price range signals the company is now closer to setting a final offering price. The proposed ticker is VOGX.
Investors watching this deal will want to track when a final price is set and shares begin trading. As of the filing, no final price has been established.
Mentioned: VOGX
Sponsored
_________________________________
What's Your Number...?
Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________